Back to Results

Tempus AI Inc (TEM)

Featured in Rapid Revenue Growth High-Beta Stocks

Tempus AI Inc. is a healthcare technology company listed on NASDAQ under the ticker TEM. The company develops tools and services that connect clinical workflows with diagnostics, analytics, and multimodal data. Its Tempus platform links a clinician’s desktop with laboratory capabilities and data resources, while Hub is designed to support healthcare providers using next-generation sequencing tests. Tempus also offers Lens for life sciences and precision research, along with diagnostics services that include NGS diagnostics, PCR profiling, and anatomic and molecular pathology testing. Its broader portfolio includes large-panel solid tumor and hematologic assays, inherited-condition genetic tests, pharmacogenomic testing for certain psychiatric conditions, clinical trial matching through Trials, an AI platform called Next, and algorithm-based diagnostics applications through Algos. The company also licenses de-identified clinical, molecular, and imaging data through Insights and provides tumor-derived biological modeling through Organoids. Tempus AI maintains strategic collaborations with companies including AstraZeneca, Pathos AI, GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, and it also works with Blood Cancer United on a pediatric acute myeloid leukemia registry.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-TEM
$46
-7.2% Downside
Fair
$66.57
34.3% Upside
Undervalued
Fair
—
—
—
0.0%
July 30, 2026
-29.4x
21.4x
6.5x
8.693 B
9.484 B
13.2%
63.6%
1.4
—
70.3%
Send a message
Valuation • Fair Value

Tempus AI Inc (NASDAQ-TEM) Fair Value by Valuation Model

Compare the primary fair value estimate for Tempus AI Inc (NASDAQ-TEM) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$46

Estimated downside of 7.2% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$46

Comparable-company valuation reference.

Analyst Price Target

$66.57

Analysts imply upside of 34.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Tempus AI Inc (NASDAQ-TEM) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Tempus AI Inc (NASDAQ-TEM)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.364 B

Current operating scale indicator.

Revenue Forecast

1.592 B

Forward revenue estimate.

EBITDA

-185.2 M

Current operating profitability reference.

EBITDA Forecast

65 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Tempus AI Inc (NASDAQ-TEM) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Tempus AI Inc (NASDAQ-TEM)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.48

No elevated caution signal from this screen.

Altman Z-Score

1.4

Lower score that deserves closer risk review.

FCF / Net Income

70.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Tempus AI Inc (NASDAQ-TEM). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Tempus AI Inc (NASDAQ-TEM)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Tempus AI Inc (NASDAQ-TEM), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Tempus AI Inc (NASDAQ-TEM) Stock Forecast & Technical Outlook

Review Tempus AI Inc (NASDAQ-TEM) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Tempus AI Inc (NASDAQ-TEM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Tempus AI Inc (NASDAQ-TEM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Tempus AI Inc (NASDAQ-TEM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Tempus AI Inc (NASDAQ-TEM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Tempus AI Inc (NASDAQ-TEM) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Tempus AI Inc (NASDAQ-TEM)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Tempus AI Inc (NASDAQ-TEM) has a Hold consensus, with 7 buy, 7 hold and 1 sell recommendations in the current data set.

Buy 7
Hold 7
Sell 1
FAQ • Fast Investor Answers

Tempus AI Inc (NASDAQ-TEM) Stock FAQ

Quick answers about Tempus AI Inc (NASDAQ-TEM) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$46
Estimated downside 7.2%
Valuation Rating
Overvalued
Estimated downside of 7.2%
Analyst Target
$66.57
Implied upside 34.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Tempus AI Inc (NASDAQ-TEM) is $46. This implies an estimated downside of 7.2% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.2% versus the current market price.

The available analyst price target for Tempus AI Inc (NASDAQ-TEM) is $66.57. The analyst target implies estimated upside of 34.3%.

The current financial health read for Tempus AI Inc (NASDAQ-TEM) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Tempus AI Inc (NASDAQ-TEM) is July 30, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Tempus AI Inc (NASDAQ-TEM) is -29.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Tempus AI Inc is 8.693 B.

The current enterprise value listed for Tempus AI Inc is 9.484 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Tempus AI Inc is NASDAQ-TEM, and the stock is listed on NASDAQ.

Tempus AI Inc (NASDAQ-TEM) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Tempus AI Inc is 13.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Tempus AI Inc is 63.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on NASDAQ View more

Illumina Inc (ILMN) Illumina Inc (ILMN)
Medpace Holdings Inc (MEDP) Medpace Holdings Inc (MEDP)
ICON PLC (ICLR) ICON PLC (ICLR)
Bio-Techne Corp (TECH) Bio-Techne Corp (TECH)
Bruker Corporation (BRKR) Bruker Corporation (BRKR)
Repligen Corporation (RGEN) Repligen Corporation (RGEN)
10X Genomics Inc (TXG) 10X Genomics Inc (TXG)
Sotera Health Co (SHC) Sotera Health Co (SHC)
Adaptive Biotechnologies Corp (ADPT) Adaptive Biotechnologies Corp (ADPT)
Maravai Lifesciences Holdings Inc (MRVI) Maravai Lifesciences Holdings Inc (MRVI)
Abcellera Biologics Inc (ABCL) Abcellera Biologics Inc (ABCL)
Fortrea Holdings Inc (FTRE) Fortrea Holdings Inc (FTRE)
BioLife Solutions Inc (BLFS) BioLife Solutions Inc (BLFS)
Personalis Inc (PSNL) Personalis Inc (PSNL)
Azenta Inc (AZTA) Azenta Inc (AZTA)
Cryoport Inc (CYRX) Cryoport Inc (CYRX)
Evotec SE ADR (EVO) Evotec SE ADR (EVO)
Cytek Biosciences Inc (CTKB) Cytek Biosciences Inc (CTKB)
Mesa Laboratories Inc (MLAB) Mesa Laboratories Inc (MLAB)
Pacific Biosciences of California (PACB) Pacific Biosciences of California (PACB)
Standard Biotools Inc (LAB) Standard Biotools Inc (LAB)
OmniAb Inc (OABI) OmniAb Inc (OABI)
Alpha Teknova Inc (TKNO) Alpha Teknova Inc (TKNO)
Nautilus Biotechnology Inc (NAUT) Nautilus Biotechnology Inc (NAUT)